Treat-to-target in psoriatic arthritis-cost-effective in the biosimilar era.

Lancet Rheumatol

Leeds Institute of Rheumatic and Musculoskeletal Medicine, University of Leeds, Leeds, UK.

Published: June 2022

Download full-text PDF

Source
http://dx.doi.org/10.1016/S2665-9913(22)00101-1DOI Listing

Publication Analysis

Top Keywords

treat-to-target psoriatic
4
psoriatic arthritis-cost-effective
4
arthritis-cost-effective biosimilar
4
biosimilar era
4
treat-to-target
1
arthritis-cost-effective
1
biosimilar
1
era
1

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!